Today’s complex clinical trials yield data sets that are almost unimaginably large and complex. As a result, the process of transforming trial data into usable knowledge simply cannot be accomplished using traditional presentation methods such as conventional charts and graphs.

Owlstone Nanotech, the developers of a promising new lung cancer detection instrument have announced they are now moving their device into clinical trials. The trials are said to begin later this year in a rapid access lung cancer clinic at Glenfield Hospital in Leicester, England.

Statistical Solutions is 30 years old, and we would like to thank all of our wonderful, loyal customers for all your support over the last 3 decades!!! Thank you and best wishes from all the team at Statistical Solutions. Read more about our history here.

To all our wonderful customers and friends in the US.

Wishing you a very happy 4th July.

Homeward bound from DIA 2014 50th Annual Meeting in San Diego. Big thank you to all the organisers for doing such a great job. This year excelled itself with so many excellent talks, workshops, tutorials and symposiums. See you all again next year.